This effect is mainly used to activate α, β, or mixed α and β receptor agonists.
| NO. | PubChem ID | CAS Number | Molecular Name | Efficacy | Efficacy_Chinese |
|---|---|---|---|---|---|
| 11 | 72300 | 528-43-8 | 2-(2-hydroxy-5-prop-2-enylphenyl)-4-prop-2-enylphenol | pseudoepinephrine | 拟肾上腺素 |
| 12 | 73111 | 0 | (9R)-9-[(9R)-2-carboxy-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid | pseudoepinephrine | 拟肾上腺素 |
| 13 | 79023 | 490-03-9 | 2-hydroxy-3-methyl-6-propan-2-ylcyclohex-2-en-1-one | pseudoepinephrine | 拟肾上腺素 |
| 14 | 79518 | 5445-31-8 | 2-methylnonan-3-one | pseudoepinephrine | 拟肾上腺素 |
| 15 | 92139 | 644-30-4 | 1-methyl-4-(6-methylhept-5-en-2-yl)benzene | pseudoepinephrine | 拟肾上腺素 |
| 16 | 441957 | 0 | [(2S,3R,4R,5S,6S)-3-acetyloxy-2-[[(1S,2R,5R,7S,10R,11R,14R,15S,16S,18R,20S)-7-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-16-yl]oxy]-5-hydroxy-6-methyloxan-4-yl] acetate | pseudoepinephrine | 拟肾上腺素 |
| 17 | 442894 | 495-59-0 | 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline | pseudoepinephrine | 拟肾上腺素 |
| 18 | 445354 | 0 | (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol | pseudoepinephrine | 拟肾上腺素 |
| 19 | 540150 | 0 | [20,22,23,25-tetraacetyloxy-21-(acetyloxymethyl)-15,26-dihydroxy-3,15,26-trimethyl-6,16-dioxo-2,5,17-trioxa-11-azapentacyclo[16.7.1.01,21.03,24.07,12]hexacosa-7(12),8,10-trien-19-yl] benzoate | pseudoepinephrine | 拟肾上腺素 |
| 20 | 699414 | 943-89-5 | (E)-3-(4-methoxyphenyl)prop-2-enoic acid | pseudoepinephrine | 拟肾上腺素 |